Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

Raven,

the audience is segmented - most of what you present is for traders, not value investors - you may be making a mistake in estimating how many there are of each - after years of Qaz telling us LTHs what a waste of time OXB was (especially when we got to 7p, those who saw the value continued buying on the dips, with real money - we continue to do this - your role is useful because in a relatively illiquid stock it helps to create the dips - but do i care if (having bought more today with real cash)it goes down to 24p, 20p? - no i don't - its just another buying opportunity - and it has no stress whatever associated with it - nice to have cash